Researcher.Life Logo

Drug Metabolism Reviews : Impact Factor & More

eISSN: 1097-9883pISSN: 0360-2532

Aims and Scope of Drug Metabolism Reviews

Established in 1972, Drug Metabolism Reviews is an academic journal that publishes review articles on all aspects of drug metabolism research. It is the official journal of the International Society for the Study of Xenobiotics (ISSX). Less

Key Metrics

CiteScore
8.8
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Pharmacology (medical)
SNIP
1.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Metabolism Reviews

Drug Metabolism Reviews Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Metabolism Reviews ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Metabolism Reviews

Metabolism of new drug modalities research advances – 2025 year in review
  • 13 May 2026
  • Drug Metabolism Reviews
Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
  • 12 May 2026
  • Drug Metabolism Reviews
Pharmacomicrobiomics in Precision Pharmacotherapy: Bidirectional Microbial-Drug Interactions as a Key Determinant of Therapeutic Response
  • 7 May 2026
  • Drug Metabolism Reviews
Population pharmacokinetics of levofloxacin: a systematic review
  • 6 May 2026
  • Drug Metabolism Reviews
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry
  • 6 May 2026
  • Drug Metabolism Reviews
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
  • 6 May 2026
  • Drug Metabolism Reviews
Metabolism of new drug modalities research advances – 2025 year in review
  • 13 May 2026
  • Drug Metabolism Reviews
Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
  • 12 May 2026
  • Drug Metabolism Reviews
Pharmacomicrobiomics in Precision Pharmacotherapy: Bidirectional Microbial-Drug Interactions as a Key Determinant of Therapeutic Response
  • 7 May 2026
  • Drug Metabolism Reviews
Population pharmacokinetics of levofloxacin: a systematic review
  • 6 May 2026
  • Drug Metabolism Reviews
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry
  • 6 May 2026
  • Drug Metabolism Reviews
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
  • 6 May 2026
  • Drug Metabolism Reviews

FAQs on Drug Metabolism Reviews